Zobrazeno 1 - 10
of 218
pro vyhledávání: '"B. Neff"'
Publikováno v:
Earth System Dynamics, Vol 7, Iss 2, Pp 397-418 (2016)
IceBern2D is a vertically integrated ice sheet model to investigate the ice distribution on long timescales under different climatic conditions. It is forced by simulated fields of surface temperature and precipitation of the Last Glacial Maximum and
Externí odkaz:
https://doaj.org/article/5b6c068852d548ffa7b48dc32bb60693
Autor:
W. R. Simpson, R. von Glasow, K. Riedel, P. Anderson, P. Ariya, J. Bottenheim, J. Burrows, L. J. Carpenter, U. Frieß, M. E. Goodsite, D. Heard, M. Hutterli, H.-W. Jacobi, L. Kaleschke, B. Neff, J. Plane, U. Platt, A. Richter, H. Roscoe, R. Sander, P. Shepson, J. Sodeau, A. Steffen, T. Wagner, E. Wolff
Publikováno v:
Atmospheric Chemistry and Physics, Vol 7, Iss 16, Pp 4375-4418 (2007)
During springtime in the polar regions, unique photochemistry converts inert halide salt ions (e.g. Br−) into reactive halogen species (e.g. Br atoms and BrO) that deplete ozone in the boundary layer to near zero levels. Since their discovery in th
Externí odkaz:
https://doaj.org/article/cade3631f75544eca5f758f866b33982
Publikováno v:
Physical Review Special Topics. Accelerators and Beams, Vol 15, Iss 11, p 112801 (2012)
In order to continuously monitor the intensity and position of an electron beam of a few hundred pA, a system of resonant cavities has been set up. The current measurement relies on signals of a few fW power extracted out of a cylindrical resonator,
Externí odkaz:
https://doaj.org/article/54b2fa0281f1422fa1b84da104a51534
Autor:
Richa, Wardhan, Vrinda, Patel, Andrew B, Neff, R B, Cook, Jeffrey D, White, Terrie, Vasilopoulos
Publikováno v:
American Journal of Infection Control. 51:194-198
We analyzed the qualitative fit test results of the filtering facepiece respirators (FFRs) used at our institution to determine their performance and utility.We retrospectively analyzed 12,582 qualitative fit testing results for several FFR models am
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::491416157e684d34bed4f6bfb0fa472b
https://doi.org/10.1016/j.ajic.2022.05.022
https://doi.org/10.1016/j.ajic.2022.05.022
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Khalil G. Saikali, Tyson Lee, Lynda A. Szczech, Ming Zhong, Dustin J. Little, John Houghton, Mark T. Houser, Robert Leong, Robert Provenzano, Lars Frison, Thomas B. Neff
Publikováno v:
Clin J Am Soc Nephrol
Background and objectives We evaluated the efficacy and cardiovascular safety of roxadustat versus placebo by analyzing data pooled from three phase 3 studies of roxadustat in patients with non–dialysis-dependent CKD and CKD-related anemia. Design,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ec68d1a745ebbdce559e0f32e41590d
https://doi.org/10.2215/cjn.16191020
https://doi.org/10.2215/cjn.16191020
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Charles Bradley, Lona Poole, Robert Leong, Anatole Besarab, Liubov Eremeeva, Lynda A. Szczech, Meraf Eyassu, Thomas B. Neff, Kin-Hung Peony Yu, Evgeny Shutov, Cameron Liu, Robert Provenzano, Gopal Saha, Svitlana Korneyeva
Publikováno v:
Nephrology Dialysis Transplantation. 36:1717-1730
Background We evaluated the efficacy and safety of roxadustat versus epoetin alfa for the treatment of chronic kidney disease-related anemia in patients new to dialysis. Methods HIMALAYAS was a Phase 3, open-label, epoetin alfa-controlled trial. Elig
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bfb75680793426ec819f4ff73c2ac112
https://doi.org/10.1093/ndt/gfab051
https://doi.org/10.1093/ndt/gfab051
Autor:
James Chou, Thomas B. Neff, James A. Tumlin, Stefan Hemmerich, R. Zabaneh, Robert Provenzano, K. H. Peony Yu
Publikováno v:
Journal of Clinical Pharmacology
Roxadustat (FG‐4592), an oral hypoxia‐inducible factor prolyl hydroxylase inhibitor that stimulates erythropoiesis, was evaluated in a phase 1b study in patients with end‐stage renal disease with anemia on hemodialysis. Seventeen patients, on e
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dcff0afc5a01e9ef37f2c3aa20428577
https://doi.org/10.1002/jcph.1648
https://doi.org/10.1002/jcph.1648
Autor:
David C. Gervasi, Christian H. Kjaergaard, Mitchell C. Brenner, Ingrid Langsetmo, Volkmar Guenzler, Pierre E. Signore, Steve J. Klaus, Guangjie Guo, Ughetta del Balzo, Todd W. Seeley, Gail Walkinshaw, F. Aisha Chow, Thomas B. Neff, Al Y. Lin, David Y. Liu, Lee A. Flippin, Qingjian Wang, Michael P. Arend
Publikováno v:
Journal of Pharmacology and Experimental Therapeutics. 374:342-353
Anemia of chronic kidney disease (CKD) is a multifactorial disorder caused by impaired erythropoietin (EPO) production and altered iron homeostasis associated with inflammation. Hypoxia-inducible factor (HIF) is a transcription factor that stimulates
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60137ae1e3d7ebca43c18369938a576c
https://doi.org/10.1124/jpet.120.265181
https://doi.org/10.1124/jpet.120.265181